Bharat Biotech’s Rotavirus Vaccine Can Increase The Risk Of Bowel Gangrene In Babies

According to a recent study published on June 11, 2024, by Brian Hooker and Dr. Jacob Puliyel in the International Journal of Risk and Safety in Medicine, Bharat Biotech's Rotavac vaccine can increase the risk of bowel gangrene in babies due to intussusception.

According to a recent study, intestinal problems may result from Rotovac, an indigenous rotavirus vaccine produced by Bharat Biotech. The International Journal of Risk and Safety in Medicine published the study's conclusions. The vaccine, which is a component of the government immunization program, has been linked to a higher incidence of intussusception in infants, the study claims.

When one section of the intestine slides into the other, a dangerous condition known as intussusception occurs. If left untreated, this illness could result in intestinal gangrene or even death.

The study, co-authored by Brian Hooker of Children's Health Defense and Jacob Puliyel, MD of the International Institute of Health Managemen...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].